CIK 0001433607
- Non-accelerated filer
- Smaller reporting company
InspireMD, Inc.
Sign in to watch- Ticker
- NSPR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262123838
- Phone
- +1 888-776-6804
- Business address
- 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
- Former names
- Saguaro Resources, Inc.
- Open-market buys, last 90 days
- $455,001
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$455,001. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Slosman Marvin CEO and President | Purchase | +46,154 | $0.65 | $30K | 3,602,812 |
| 2026-11-13 | Slosman Marvin CEO and President | Purchase · Series L Common Stock Warrant | +34,616 | 34,616 | ||
| 2026-05-12 | Slosman Marvin CEO and President | Purchase | +21,000 | $1.20 | $25K | 3,556,658 |
| 2026-01-14 | Slosman Marvin CEO and President | Grant or award | +1,114,792 | 3,535,658 | ||
| 2025-07-30 | Slosman Marvin CEO and President | Purchase | +10,330 | $2.42 | $25K | 2,420,866 |
| 2025-01-07 | Slosman Marvin CEO and President | Grant or award | +558,417 | 2,410,536 | ||
| 2025-01-07 | Slosman Marvin CEO and President | Grant or award · Options to purchase common stock (right to buy) | +254,985 | 937,796 | ||
| 2024-01-23 | Slosman Marvin CEO and President | Grant or award | +563,499 | 1,852,119 | ||
| 2024-01-23 | Slosman Marvin CEO and President | Grant or award · Options to purchase common stock (right to buy) | +215,405 | 682,811 | ||
| 2023-05-17 | Slosman Marvin CEO and President | Grant or award | +1,045,150 | 1,288,620 | ||
| 2023-05-17 | Slosman Marvin CEO and President | Grant or award · Options to purchase common stock (right to buy) | +348,380 | 467,406 | ||
| 2021-10-13 | Slosman Marvin CEO and President | Grant or award | +146,567 | 243,470 | ||
| 2021-10-13 | Slosman Marvin CEO and President | Grant or award · Options to purchase common stock (right to buy) | +48,855 | 48,855 | ||
| 2021-04-19 | Slosman Marvin CEO and President | Grant or award · Option to Purchase Common Stock | +600,000 | 1,052,556 | ||
| 2021-02-08 | Slosman Marvin CEO and President | Purchase | +40,320 | $0.62 | $25K | 1,453,538 |
| 2021-02-08 | Slosman Marvin CEO and President | Purchase · Warrants | +20,160 | $0.62 | $12K | 75,710 |
| 2020-08-31 | Slosman Marvin CEO and President | Grant or award · Options (right to buy) | +391,762 | 452,556 | ||
| 2020-08-31 | Slosman Marvin CEO and President | Grant or award | +1,175,287 | 1,413,218 | ||
| 2020-08-31 | Slosman Marvin CEO and President | Grant or award · Options (right to buy) | +391,762 | 452,556 | ||
| 2020-06-05 | Slosman Marvin CEO and President | Purchase | +55,550 | $0.45 | $25K | 237,931 |
Page 1 of 2 · 23 trades